From 2 November 2020, the autumn semester 2020 will take place online. Exceptions: Courses that can only be carried out with on-site presence.
Please note the information provided by the lecturers via e-mail.

Roger Schibli: Catalogue data in Autumn Semester 2017

Name Prof. Dr. Roger Schibli
FieldRadiopharmacy
Consultation hoursBy appointment
Address
Inst. f. Pharmazeutische Wiss.
ETH Zürich, HCI H 431
Vladimir-Prelog-Weg 1-5/10
8093 Zürich
SWITZERLAND
Telephone+41 44 633 74 64
Fax+41 44 633 13 67
E-mailroger.schibli@pharma.ethz.ch
DepartmentChemistry and Applied Biosciences
RelationshipFull Professor

NumberTitleECTSHoursLecturers
535-0001-00LIntroduction to Pharmaceutical Sciences I2 credits2VC. Halin Winter, K.‑H. Altmann, S. M. Ametamey, M. Detmar, B. A. Gander, J. Hall, J.‑C. Leroux, C. Müller, D. Neri, U. Quitterer, R. Schibli, G. Schneider, H. U. Zeilhofer
AbstractFirst identification with Pharmaceutical Sciences; motivation for profiling in the Natural Sciences, which are focused on within the first two years as a preparation for the specialized studies; sensitization for the duties and the responsibilities of a person with a federal diploma in Pharmacy; information about job opportunities.
ObjectiveFirst identification with Pharmaceutical Sciences; motivation for profiling in the Natural Sciences as a preparation for the specialized studies; sensitization for the duties and the responsibilities of a person with a federal diploma in Pharmacy; information about job opportunities.
ContentIntroduction to Pharmaceutical Sciences by selected milestones of research and development. Overview on research activities at the Institute of Pharmaceutical Sciences that is focussed on drug delivery and development (from concepts to prototypes). Sensitization for communication skills and information management. Demonstration of job opportunities in community pharmacies, in the hospital, in industry, and in the public sector by experts in the different fields.
Lecture notesHandouts for individual lectures.
Prerequisites / NoticeInteractive teaching
535-0011-00LDrug Seminar Restricted registration - show details
The course is reserved for students registered in the Master's programme in Pharmacy or in Pharmaceutical Sciences
5 credits9SC. Halin Winter, K.‑H. Altmann, S. M. Ametamey, M. Detmar, B. A. Gander, J. Hall, S.‑D. Krämer, J.‑C. Leroux, C. Müller, D. Neri, V. I. Otto, U. Quitterer, R. Schibli, G. Schneider, C. Steuer, H. U. Zeilhofer
AbstractThe course provides a platform for the investigation, presentation and discussion of a topic with relevance to the field of pharmaceutical sciences. Students work in small groups on a chosen topic, they write a mini-review and present their work on a one day symposium.
ObjectiveThe main objectives of this course are:

- students develop their scientific reflection (Critical Thinking) and working skills by working independently on a relevant pharmaceutical topic
- students gain in-depth knowledge of the topic investigated
- students train their scientific writing and presentation skills
- students train their ability to plan a project and work in a team
ContentThe Course Drug Seminar takes place during the first 7 weeks of the 1. Master semester. It is a compulsory course of the MSc Pharmacy curriculum and an elective course in the MSc PharmSciences.

The course provides a platform for the investigation, presentation and discussion of a topic with relevance to the field of pharmaceutical sciences.

During the course, students work in small teams on a topic of their choice and elaborate a written mini-review and an oral presentation. Each team is tutored by a lecturer of the Institute of Pharmaceutical Sciences. The work is mainly based on literature search / review, but may also involve conducting interviews or site visits, if appropriate. The final presentations of all groups will take place in the framework of a dedicated Symposium held in the middle of the semester.
Prerequisites / NoticeOnly for students of MSc Pharmacy and MSc Pharmaceutical Sciences.
535-0210-00LRadiopharmaceutical Chemistry2 credits2VR. Schibli, S. M. Ametamey
AbstractIntroduction of basic principles of radiation, structure and function of radiopharmaceuticals, examples of radiopharmaceuticals in nuclear medicine pactice, discussion of functional radiopharmaceuticals,molecular imaging, targeted radionuclide therapy, radiopharmaceutical synthesis.
ObjectiveIntroduction of basic priciple of radiation, structure and function of radiopharmaceuticals, examples of radiopharmaceuticals in nuclear medicine pactice, discussion of functional radiopharmaceuticals,molecular imaging, targeted radionuclide therapy, radiopharmaceutical synthesis.
ContentIntroduction radioactivity, radiopharmaceuticals, PET- and SPET- nuclides, radionuclide generators, radiopharmaceuticals for imaging the heart, infection- and lungdiagnostics, groups of brain radiopharmaceuticals, PET-kinetik modelling, molecular imaging, application in nuclear medicine, tumor-affine radiopharmaceuticals, targeted radionuclidetherapy, radioimunoconjugates, dosis calculations, nuclearmedicine prcatice, radiopharmaceutical chemistry.
Lecture noteshttps://ilias-app2.let.ethz.ch/goto.php?target=crs_115827&client_id=ilias_lda
LiteratureReference book:
Gopal B. Saha, Ph.D, Fundamentals of Nuclear Pharmacy; Verlag: Springer New York; Auflage: 6th ed. (3. November 2010)
Sprache: Englisch
ISBN-10: 1441958592
ISBN-13: 978-1441958594

-available at the Polybuchhandlung
Prerequisites / NoticePrerequisites: basic knowledge in physics and chemsitry
535-0900-00LSeminars on Drug Discovery and Development1 credit1KJ.‑C. Leroux, K.‑H. Altmann, S. M. Ametamey, M. Detmar, B. A. Gander, C. Halin Winter, J. Hall, D. Neri, U. Quitterer, R. Schibli, G. Schneider, H. U. Zeilhofer
AbstractState-of-the-art information on drug discovery and development by experts from academia and industry.
ObjectiveState-of-the-art information on drug discovery and development.
ContentSeminar series of the Institute of Pharmaceutical Sciences. Experts from academia and industry report on relevant topics.
541-0007-00LModule 7: Clinical Development Restricted registration - show details
Only for CAS in Pharmaceuticals.

The enrolment is done by the CAS in Pharmaceuticals study administration.
2.5 credits3GR. Furegati Hafner, R. Schibli
AbstractModule 7 gives an overview about the several steps that have to be followed during the process of clinical development.
Objective• Preclinical bridge to clinical development
• Strategy for clinical development
• Regulatory aspects of clinical development
• Good clinical practice (GCP) and quality assurance
• First in human studies (Phase I), Proof of concept studies (Phase II), Registration studies (Phase III), Post-registration studies (Phase IV)
• Monitoring
• Organizational and financial aspects of clinical development
• Portfolio and life cycle management
• Data management and simulation of a clinical study
• Personalized medicine
541-1000-00LEssay Restricted registration - show details
Only for CAS in Pharmaceuticals.

The enrolment is done by the CAS in Pharmaceuticals study administration.
1 credit2DR. Furegati Hafner, R. Schibli
AbstractThe essay is an essential part of the CAS program „Pharmaceuticals – From Research to Market“ (CAS Pharm) and serves as final performance assessment.
ObjectiveThe essay documents the student’s competence development during the program as well as the transfer of acquired knowledge to professional practice/activities.
Literaturewww.postgraduate.pharma.ethz.ch
documents: essay
542-0001-00LModule I: Pharmacy and Legislation (University of Ljubliana, Slovenia) Restricted registration - show details
Only for CAS in Radiopharmazeutischer Chemie, Radiopharmacy.

The enrolment is done by the CAS study administration.
4 credits6GR. Schibli, R. Furegati Hafner
AbstractModule I:
Knowledge of the fundamentals of development, preparation, testing and stability of sterile radiopharmaceutical preparations.
Acquirement of basic information on European legislation in Radiopharmacy including GMP and Pharmacopoeia.
Understanding basics of gene engineering and pharmacokinetics
Objective• Good manufacturing practice (GMP) of classical radiopharmaceuticals
• GMP: industrial point of view
• Molecular and cellular aspects of radiobiology
• Pharmacopoeia
• Pharmacopoeia – how to use it
• Design of dosage forms for pharmaceuticals
• Pharmaceutical packaging
• Methods of preparation of sterile products
• Aseptic preparation
• The role of excipients in parenteral radiopharmaceutical preparations
• Sterility testing and endotoxin determination
• Particulate contamination
• Principles of medicinal chemistry
• An overview of modern pharmaceutical analysis
• Genetic engineering
• Stability and shelf-life of pharmaceuticals
• (in)stability of radiopharmaceuticals
• Legislation in radiopharmacy
• European directives – GMP
• Specific radiopharmaceutical legislation
• Clinical trials directive and related documents
• The small scale, non-commercial preparation of radiopharmaceuticals
• GMP of PET radiopharmaceuticals
• Quality assurance and preparation of SOP
• Water for pharmaceutical use
• Practicals: visit to hospital radiopharmacy
• Basic concepts of pharmacokinetics
• Drug regulatory affairs
• Microbiology in Pharmacy
• Visit to pharmaceutical company